vs

Side-by-side financial comparison of GCL Global Holdings Ltd (GCL) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

GCL Global Holdings Ltd is the larger business by last-quarter revenue ($98.7M vs $83.1M, roughly 1.2× PROCEPT BioRobotics Corp). GCL Global Holdings Ltd runs the higher net margin — -5.2% vs -38.1%, a 32.9% gap on every dollar of revenue.

GCL Global Holdings Ltd is a leading clean energy enterprise focusing on R&D, production and operation of photovoltaic products, energy storage systems and low-carbon energy solutions. Its main markets cover Asia, Europe, North America, serving utility, commercial and residential distributed energy users across the globe.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

GCL vs PRCT — Head-to-Head

Bigger by revenue
GCL
GCL
1.2× larger
GCL
$98.7M
$83.1M
PRCT
Higher net margin
GCL
GCL
32.9% more per $
GCL
-5.2%
-38.1%
PRCT

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
GCL
GCL
PRCT
PRCT
Revenue
$98.7M
$83.1M
Net Profit
$-5.1M
$-31.6M
Gross Margin
11.0%
64.9%
Operating Margin
-6.7%
-4.1%
Net Margin
-5.2%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.04
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GCL
GCL
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$98.7M
$83.3M
Q2 25
$142.1M
$79.2M
Q1 25
$69.2M
Q4 24
$68.2M
Q3 24
$36.1M
$58.4M
Q2 24
$53.4M
Net Profit
GCL
GCL
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-5.1M
$-21.4M
Q2 25
$5.6M
$-19.6M
Q1 25
$-24.7M
Q4 24
$-18.9M
Q3 24
$-1.9M
$-21.0M
Q2 24
$-25.6M
Gross Margin
GCL
GCL
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
11.0%
64.8%
Q2 25
15.0%
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
16.2%
63.2%
Q2 24
59.0%
Operating Margin
GCL
GCL
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-6.7%
-27.8%
Q2 25
2.3%
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-5.6%
-38.4%
Q2 24
-50.3%
Net Margin
GCL
GCL
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-5.2%
-25.7%
Q2 25
3.9%
-24.7%
Q1 25
-35.8%
Q4 24
-27.6%
Q3 24
-5.2%
-35.9%
Q2 24
-48.0%
EPS (diluted)
GCL
GCL
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.04
$-0.38
Q2 25
$0.05
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GCL
GCL
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$16.6M
$245.6M
Total DebtLower is stronger
$52.0M
$51.7M
Stockholders' EquityBook value
$33.1M
$347.7M
Total Assets
$159.9M
$487.1M
Debt / EquityLower = less leverage
1.57×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GCL
GCL
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$16.6M
$294.3M
Q2 25
$18.2M
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$2.7M
$196.8M
Q2 24
$214.1M
Total Debt
GCL
GCL
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$52.0M
$51.6M
Q2 25
$11.9M
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
GCL
GCL
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$33.1M
$380.3M
Q2 25
$35.9M
$385.8M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$15.9M
$241.2M
Q2 24
$251.8M
Total Assets
GCL
GCL
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$159.9M
$511.5M
Q2 25
$101.6M
$513.1M
Q1 25
$519.4M
Q4 24
$534.0M
Q3 24
$49.6M
$374.1M
Q2 24
$374.4M
Debt / Equity
GCL
GCL
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
1.57×
0.14×
Q2 25
0.33×
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GCL
GCL
PRCT
PRCT
Operating Cash FlowLast quarter
$-4.8M
Free Cash FlowOCF − Capex
$-5.2M
FCF MarginFCF / Revenue
-5.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GCL
GCL
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$-4.8M
$-6.6M
Q2 25
$-10.3M
$-15.0M
Q1 25
$-17.0M
Q4 24
$-32.4M
Q3 24
$6.1M
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
GCL
GCL
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-5.2M
$-9.5M
Q2 25
$-10.5M
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
GCL
GCL
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-5.3%
-11.4%
Q2 25
-7.4%
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
GCL
GCL
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
0.4%
3.4%
Q2 25
0.1%
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
GCL
GCL
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
-1.84×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GCL
GCL

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons